Search Results 421-430 of 17362 for Teratogenic
Biological therapies, such as talimogene laherparepvec, use substances made from living organisms that may stimulate or suppress the immune system in different ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity ...
This inherited condition causes polyps to grow in the digestive tract and increases the risk of cancer. Regular screening helps reduce some risks.
About this study. Compare transapical and transfemoral TAVR as regards clinical outcomes (both beneficial including improvement in heart failure class ...
Heart Failure. Rick A. Nishimura, MD ...............................46. Steve R. Ommen, MD ..................................47. Garvan C. Kane, MD, PhD .
About this study. This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the ...
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...
About this study. To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.